Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Palivizumab in viral respiratory infections].

× No keyword cloud information.

4 in total

1. Safety, tolerance and pharmacokinetics of a humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. MEDI-493 Study Group.

Authors: K N Subramanian; L E Weisman; T Rhodes; R Ariagno; P J Sánchez; J Steichen; L B Givner; T L Jennings; F H Top; D Carlin; E Connor
Journal: Pediatr Infect Dis J Date: 1998-02 Impact factor: 2.129

2. Deaths among children less than two years of age receiving palivizumab: an analysis of comorbidities.

Authors: Aparna K Mohan; M Miles Braun; Susan Ellenberg; Judith Hedje; Timothy R Coté
Journal: Pediatr Infect Dis J Date: 2004-04 Impact factor: 2.129

3. Safety and pharmacokinetics of palivizumab therapy in children hospitalized with respiratory syncytial virus infection.

Authors: Xavier Sáez-Llorens; María T Moreno; Octavio Ramilo; Pablo J Sánchez; Franklin H Top; Edward M Connor
Journal: Pediatr Infect Dis J Date: 2004-08 Impact factor: 2.129

4. Safety and pharmacokinetics of an intramuscular humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. The MEDI-493 Study Group.

Authors: X Sáez-Llorens; E Castaño; D Null; J Steichen; P J Sánchez; O Ramilo; F H Top; E Connor
Journal: Pediatr Infect Dis J Date: 1998-09 Impact factor: 2.129

4 in total